AFFYXELL THERAPEUTICS
AffyXell was established in January 2020 by Avacta and Daewoong as a joint venture to develop novel mesenchymal stem cell (MSC) therapies.
AFFYXELL THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Total Employee:
1+
Status:
Active
Total Funding:
7.3 M USD
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Investors List
Avacta Group
Avacta Group investment in Corporate Round - AffyXell Therapeutics
Shinhan Venture Investment
Shinhan Venture Investment investment in Series A - AffyXell Therapeutics
Kolon Investment
Kolon Investment investment in Series A - AffyXell Therapeutics
Samsung Venture Investment
Samsung Venture Investment investment in Series A - AffyXell Therapeutics
Shinhan Investment
Shinhan Investment investment in Series A - AffyXell Therapeutics
Stonebridge Ventures
Stonebridge Ventures investment in Series A - AffyXell Therapeutics
Gyeongnam Venture Investment
Gyeongnam Venture Investment investment in Series A - AffyXell Therapeutics
Smilegate Investment
Smilegate Investment investment in Series A - AffyXell Therapeutics